AMBALAL SARABHAI ENT L vs ZYDUS LIFESCIENCES LTD
A side-by-side comparison of AMBALAL SARABHAI ENT L (AMBALALSA) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, ZYDUS LIFESCIENCES LTD leads AMBALALSA vs ZYDUSLIFE on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ZYDUSLIFE takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
AMBALALSA takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
ZYDUSLIFE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 43.9% CAGR over last 5 years"]
- − ["Stock is trading at 5.67 times its book value", "Promoter holding is low: 31.4%", "Tax rate seems low", "Company has a low return on equity of 12.1% over last 3 years.", "Earnings include an other income of Rs.9.11 Cr.", "Working capital days have increased from 267 days to 1,379 days"]
- + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.